References
- AAPCC (American Association of Poison Control Centers). 2007. National Poison Data System (NPDS) reference manual part 2 - System information manual. Alexandria, Virginia: American Association of Poison Control Centers.
- Barratt, M. J., V. Cakic, and S. Lenton. 2013. Patterns of synthetic cannabinoid use in Australia. Drug and Alcohol Review 32:141–46. doi:10.1111/j.1465-3362.2012.00519.x.
- Bonar, E. E. 2014. Synthetic cannabinoid use among patients in residential substance use disorder treatment: Prevalence, motives, and correlates. Drug and Alcohol Dependence 143:268–71. doi:10.1016/j.drugalcdep.2014.07.009.
- Centers for Disease Control and Prevention. 2013a. Acute kidney injury associated with synthetic cannabinoid use - multiple States. Morbidity and Mortality Weekly Report 62: 93–98.
- Centers for Disease Control and Prevention. 2013b. Notes from the field: Severe illness associated with synthetic cannabinoid use - Brunswick, Georgia. Morbidity and Mortality Weekly Report 62: 39.
- Drug Enforcement Administration. National Forensic Information System. Accessed https://www.nflis.deadiversion.usdoj.gov/Login.aspx?ReturnUrl=%2fDQS.aspx
- Drug Enforcement Administration. 2018. DEA emerging threat report: First quarter. Accessed https://ndews.umd.edu/resources/dea-emerging-threat-reports.
- Fantegrossi, W. E., J. S. Moran, A. Radominska-Pandya, and P. L. Prather. 2014. Distinct pharmacology and metabolism of KW synthetic cannabinoids compared to Delta-THC: Mechanism underlying greater toxicity? Life Sciences 97:45–54. doi:10.1016/j.lfs.2013.09.017.
- Forrester, M. B., K. Kleinschmidt, E. Schwarz, and A. Young. 2011. Synthetic cannabinoid exposures reported to Texas poison centers. Journal of Addictive Diseases 30:351–58. doi:10.1080/10550887.2011.609807.
- Hall, J. N. National Drug Early Warning System (NDEWS) Southeastern Florida Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017: SCE Narrative. At https://ndews.umd.edu/sites/ndews.umd.edu/files/florida-scs-drug-use-patterns-and-trends-2017-final.pdf
- Hill, S. L., G. A. Cooper, G. Jackson, D. J. Lupton, S. Bradberry, and S. H. Thomas. 2013. What’s on the ‘Spice’ rack? Synthetic cannabinoid receptor agonist toxicity reported to the UK National Poisons information service. Clinical Toxicology (Phila) 51:345.
- Hoyte, C. O., J. Jacob, A. A. Monte, M. Al-Jumaan, A. C. Bronstein, and K. J. Heard. 2012. A characterization of synthetic cannabinoid exposures reported to the national poison data system in 2010. Annals of Emergency Medicine 60:435–38. doi:10.1016/j.annemergmed.2012.03.007.
- Iwanicki, JL, and DJ. Cao. 2014. Hoppe j et al. Novel Synthetic Cannabinoid Outbreak Causing Severe Illness. Clin. Toxicol (Phila.) 52:402.
- Law, R., J. Schier, C. Martin, A. Chang, and A. Wolkin Notes from the field: Increase in reported adverse health effects related to synthetic cannabinoid use - United States, January-May 2015, Morbidity and Mortality Weekly Report, 64 (2015): 618–19.
- Manseau, M. W., A. Rajparia, A. Joseph, S. Azarchi, D. Goff, R. Salatodiya, and C. Fuller Lewis. 2017. Clinical characteristics of synthetic cannabinoid use in a large urban psychiatric emergency setting. Substance Use and Misuse 52:822–25. doi:10.1080/10826084.2016.1263663. Accessed
- Maxwell, J. C. 2017. Substance abuse trends in Texas. University of Texas at Austin Steve Hicks of Social Work. Accessed https://socialwork.utexas.edu/dl/ari/texas-drug-trends-2017.pdf.
- Papadopoulos, E. A., K. R. Cummings, J. M. Marraffa, K. M. Aldous, L. Li, and N. Ahmad. 2017. Reports of adverse health effects related to synthetic cannabinoid use in New York State. American Journal on Addictions 26:772–75. doi:10.1111/ajad.12636.
- Schwartz, M. D., J. Trecki, L. A. Edison, A. R. Steck, J. K. Arnold, and R. R. Gerona. 2015. A common source outbreak of severe delirium associated with exposure to the novel synthetic cannabinoid ADB-PINACA. Journal of Emergency Medicine 48:573–80. doi:10.1016/j.jemermed.2014.12.038.
- Shanks, K. G., T. Dahn, G. Behonick, and A. Terrell. 2012. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry. Journal of Analytic Toxicology 36:360–71. doi:10.1093/jat/bks047.
- Substance Abuse and Mental Health Services. Treatment episode data set (TEDS), 2004-2014, Appendix B, TEDS Data Elements. Accessed https://www.samhsa.gov/data/sites/default/files/2014_Treatment_Episode_Data_Set_State_Admissions_9_15_16.pdf
- Trecki, J., R. R. Gerona, and M. D. Schwartz. 2015. Synthetic cannabinoid-related illnesses and deaths. New England Journal of Medicine 373:103–07. doi:10.1056/NEJMp1505328.